ARX:TSXARC Resources Ltd. Analysis
Data as of 2026-03-14 - not real-time
CA$27.57
Latest Price
6/10Risk
Risk Level: Medium
Executive Summary
ARC Resources is trading near the top of its 27‑month range at a price that sits below its DCF‑derived fair value, offering roughly a 4% upside. Technical indicators show a bullish MACD crossover and an RSI in the high‑60s, suggesting the stock is approaching overbought territory while still holding above the 20‑day SMA. The price‑to‑earnings multiple of about 12.6 is well under the industry average of 22, reinforcing the undervalued narrative. Recent material news includes a C$950 million senior note offering aimed at refinancing existing debt and an announced increase in the dividend, which improves yield sustainability. The company posted solid operating performance with revenue growth of roughly 16% and free cash flow exceeding C$800 million, supporting a 3% dividend yield and a modest payout ratio.
Fundamentally, ARC’s balance sheet shows a manageable debt‑to‑equity ratio for the sector, low beta (≈0.4) and a strong cash conversion profile, while the Montney asset base provides a stable geographic foothold. The combination of attractive valuation, sustainable dividend, and growth‑oriented cash flow targets positions the stock as a blend of value and growth, suitable for investors with a medium‑to‑long‑term horizon.
Fundamentally, ARC’s balance sheet shows a manageable debt‑to‑equity ratio for the sector, low beta (≈0.4) and a strong cash conversion profile, while the Montney asset base provides a stable geographic foothold. The combination of attractive valuation, sustainable dividend, and growth‑oriented cash flow targets positions the stock as a blend of value and growth, suitable for investors with a medium‑to‑long‑term horizon.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- RSI approaching overbought levels
- Price near immediate resistance
- Recent debt refinancing reduces near‑term financing risk
Medium Term
1–3 yearsPositive
Model confidence: 8/10
Key Factors
- Undervaluation relative to peers
- Projected cash‑flow growth of ~16%
- Sustainable 3% dividend yield
Long Term
> 3 yearsPositive
Model confidence: 8/10
Key Factors
- Low beta and stable Canadian asset base
- Continued dividend growth and payout stability
- Long‑term upside from DCF fair‑value gap
Key Metrics & Analysis
Financial Health
Revenue Growth15.60%
Profit Margin20.99%
P/E Ratio12.6
ROE15.73%
ROA7.73%
Debt/Equity47.34
P/B Ratio1.9
Op. Cash FlowCA$3.1B
Free Cash FlowCA$822.8M
Industry P/E22.2
Technical Analysis
TrendNeutral
RSI68.5
SupportCA$23.83
ResistanceCA$27.98
MA 20CA$25.62
MA 50CA$24.93
MA 200CA$26.19
MACDBullish
VolumeIncreasing
Fear & Greed Index72.88
Valuation
Fair ValueCA$30.38
Target PriceCA$28.68
Upside/Downside4.01%
GradeUndervalued
TypeBlend
Dividend Yield3.03%
Risk Assessment
Beta0.40
Volatility42.63%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.